FDA-approved Alzheimer’s drugs will be covered by Medicare, with some limitations, CMS says
Headline from KTVZ Bend
By Carma Hassan, CNN (CNN) — The Centers for Medicare & Medicaid Services announced Thursday a plan to cover a new class of Alzheimer’s disease drugs if they receive full approval from the US Food and Drug Administration – and with some limitations.
KTVZ Bend's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
By Carma Hassan, CNN (CNN) — The Centers for Medicare & Medicaid Services announced Thursday a plan to cover a new class of Alzheimer’s disease drugs if they receive full approval from the US Food and Drug Administration – and with some limitations.
FRIDAY, June 2, 2023 (HealthDay News) -- Medicare will soon cover a new class of Alzheimer's drugs if they receive full approval from the U.S. Food and Drug Administration, with
Centers for Medicare and Medicaid Services Administrator Chiquita Brooks-LaSure now promises payment for FDA traditionally approved monoclonal antibody treatments for Alzheimer’s disease. Intense lobbying, congressional criticism played a role in the decision.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
FDA-approved Alzheimer’s drugs will be covered by Medicare, with some limitations, CMS says | Since Then
